Patents by Inventor Christopher P. Carron

Christopher P. Carron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6193968
    Abstract: Monoclonal antibodies that recognize the &agr;v&bgr;3 integrin receptor complex, but do not significantly bind to &agr;IIb&bgr;IIIa, can be used in methods for treating &agr;v&bgr;3 integrin-mediated diseases, such as tunor metastasis.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: February 27, 2001
    Assignees: The Burnham Institute, G. D. Searle & Company
    Inventors: Christopher P. Carron, Debra M. Meyer, George A. Nickols, Jeffrey W. Smith
  • Patent number: 6171588
    Abstract: Monoclonal antibodies that recognize the &agr;v &bgr;3 integrin receptor complex, but do not significantly bind to &agr;IIb&bgr;IIIa, inhibit &agr;v&bgr;3 integrin-mediated diseases.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: January 9, 2001
    Assignee: G. D. Searle & Company
    Inventors: Christopher P. Carron, Debra M. Meyer, George A. Nickols
  • Patent number: 6150114
    Abstract: A method for determining the amount of an antiplatelet compound in a subject being treated with the compound which comprises calculating the ACT number of the subject's blood containing a reagent which immunoreacts with the antiplatelet compound and comparing the figure to a standardized concentration figure. In subjects concurrently being treated with heparin and antiplatelet compounds, the method can be practiced without additional heparin added to the blood sample. The invention also provides reagents which immunoreact with antiplatelet compounds and kits comprising immunoreactive reagents.
    Type: Grant
    Filed: May 15, 1997
    Date of Patent: November 21, 2000
    Assignee: G. D. Searle & Co.
    Inventors: Larry P. Feigen, Christopher P. Carron, Neal F. Haas, Debra M. Meyer, Jimmy D. Page, Jodi A. Pegg